REACT®
Showing 1 - 25 of >10,000
Convulsion, Non-Epileptic Trial in Birmingham (ReACT, Supportive Therapy)
Not yet recruiting
- Convulsion, Non-Epileptic
- ReACT
- Supportive Therapy
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 22, 2023
Diabetic Kidney Disease, CAKUT, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT))
Not yet recruiting
- Diabetic Kidney Disease
- +2 more
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jan 11, 2023
Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine
Recruiting
- Aortic Diseases
- Aortic Surgery
-
Rome, ItalyFondazione Policlinico Universitario A Gemelli IRCCS
Mar 9, 2023
Functional Seizures, Convulsion, Non-Epileptic Trial in Birmingham (ReACT, CATCH-IT)
Not yet recruiting
- Functional Seizures, Convulsion, Non-Epileptic
- ReACT
- CATCH-IT
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Apr 5, 2023
A Long-Term Follow-Up Study of Participants Exposed to REACT
Not yet recruiting
- Diabetic Kidney Disease
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jun 15, 2023
Type 2 Diabetes, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT®))
Not yet recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jan 6, 2023
Type 2 Diabetes, Chronic Kidney Disease Trial in United States (Renal Autologous Cell Therapy (REACT®))
Completed
- Type 2 Diabetes Mellitus
- Chronic Kidney Disease
- Renal Autologous Cell Therapy (REACT)
-
Tucson, Arizona
- +3 more
Jan 6, 2023
Early-stage Breast Cancer Trial in Ottawa (Endocrine Therapy and Radiotherapy)
Completed
- Early-stage Breast Cancer
- Endocrine Therapy and Radiotherapy
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Sep 28, 2022
Convulsion, Non-Epileptic Trial in Birmingham (ReACT)
Recruiting
- Convulsion, Non-Epileptic
- ReACT
-
Birmingham, AlabamaSparks Center Office of Psychiatric Research
May 4, 2022
Convulsion, Non-Epileptic Trial in Birmingham (ReACT, Supportive Therapy)
Completed
- Convulsion, Non-Epileptic
- ReACT
- Supportive Therapy
-
Birmingham, AlabamaSparks Center Office of Psychiatric Research
Mar 4, 2022
Behavior, Child Trial in Birmingham, Huntsville (CP no REACT, CP+/No REACT, CP and REACT)
Enrolling by invitation
- Behavior, Child
- CP no REACT
- +3 more
-
Birmingham, Alabama
- +1 more
Dec 30, 2021
Atrial Fibrillation Trial in United States (AFSW Guided DOAC, Continuous DOAC therapy)
Not yet recruiting
- Atrial Fibrillation
- AFSW Guided DOAC
- Continuous DOAC therapy
- (no location specified)
Apr 19, 2023
Early-stage Breast Cancer Trial in Ottawa (Zoledronate)
Active, not recruiting
- Early-stage Breast Cancer
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Apr 19, 2022
Multi-Drug Resistant Organism Trial in Decatur (Allogeneic Microbiota in Glycerol (10%) (AMG))
Not yet recruiting
- Multi-Drug Resistant Organism
- Allogeneic Microbiota in Glycerol (10%) (AMG)
-
Decatur, GeorgiaEmory Long-Term Acute Care
Mar 20, 2023
Fibromyalgia Trial in San Francisco (Digital ACT)
Recruiting
- Fibromyalgia
- Digital ACT
-
San Francisco, CaliforniaSwing Therapeutics
Feb 2, 2022
Acute Hypercapnic Respiratory Failure Trial (Trancutaneous CO2 monitoring (using TCM5 device), Arterial Blood Gas (ABG)
Not yet recruiting
- Acute Hypercapnic Respiratory Failure
- Trancutaneous CO2 monitoring (using TCM5 device)
- Arterial Blood Gas (ABG) sampling
- (no location specified)
Dec 29, 2022
Cancer Trial in Germany (CANKADO PRO-React Onco)
Recruiting
- Cancer
- CANKADO PRO-React Onco
-
Soest, GermanySchwerpunktpraxis für Hämatologie und Onkologie
Jul 11, 2022
Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract Trial in United States (Renal Autologous Cell Therapy
Recruiting
- Chronic Kidney Disease
- Congenital Anomalies of Kidney and Urinary Tract
- Renal Autologous Cell Therapy (REACT®)
-
Meridian, Idaho
- +5 more
Mar 9, 2022
Type 2 Diabetes, Chronic Kidney Diseases Trial in United States (Renal Autologous Cell Therapy (REACT®))
Recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
-
Downey, California
- +23 more
Jan 18, 2023
Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine
Not yet recruiting
- Breast Cancer
- Standard of care administration of Endocrine therapy
- Dose-frequency escalation administration of Endocrine therapy
- (no location specified)
Feb 22, 2023
Alzheimer, Apathy in Dementia Trial in Toronto (rTMS, methylphenidate)
Recruiting
- Alzheimer Disease
- Apathy in Dementia
- rTMS
- methylphenidate
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 29, 2022
Breast Cancer Trial in Ottawa (Standard of care treatments)
Completed
- Breast Cancer
- Standard of care treatments
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Nov 5, 2022
PROVIDENCE - Real-world Study in HER2-positive Unresectable or
Not yet recruiting
- Breast Neoplasms
- +2 more
- (no location specified)
Oct 7, 2022
Replication of ISAR-REACT 5 Antiplatelet Trial in Healthcare
Completed
- Acute Coronary Syndrome
- Ticagrelor 90mg
- Prasugrel 10mg
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 18, 2021